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The disruption of the NRF2 (nuclear factor erythroid-derived 2-like 2)/glutathione-mediated antioxidant defense
pathway is a critical step in the pathogenesis of several chronic pulmonary diseases and cancer. While the
mechanism of NRF2 activation upon oxidative stress has been widely investigated, little is known about the
endogenous signals that regulate the NRF2 pathway in lung physiology and pathology. Here we show that an E-box-
mediated circadian rhythm of NRF2 protein is essential in regulating the rhythmic expression of antioxidant genes
involved in glutathione redox homeostasis in the mouse lung. Using an in vivo bleomycin-induced lung fibrosis
model, we reveal a clock ‘‘gated’’ pulmonary response to oxidative injury, with a more severe fibrotic effect when
bleomycin was applied at a circadian nadir in NRF2 levels. Timed administration of sulforaphane, an NRF2
activator, significantly blocked this phenotype. Moreover, in the lungs of the arrhythmic ClockD19 mice, the levels
of NRF2 and the reduced glutathione are constitutively low, associated with increased protein oxidative damage and
a spontaneous fibrotic-like pulmonary phenotype. Our findings reveal a pivotal role for the circadian control of the
NRF2/glutathione pathway in combating oxidative/fibrotic lung damage, which might prompt new chronother-
apeutic strategies for the treatment of human lung diseases, including idiopathic pulmonary fibrosis.
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In mammals and humans, the circadian clocks in the
brain and periphery are responsible for generating ;24-h
daily rhythms that control physiology, metabolism, and
behavior (Reppert and Weaver 2002; Hastings et al. 2003).
At the molecular level, circadian rhythms emerge from
the interlocked transcriptional/translational feedback
loops consisting of core clock genes and oscillatory
metabolic products (Ko and Takahashi 2006). The core
clock transcription factors CLOCK and BMAL1 activate
the expression of repressors Period (Per) and Cryptochrome
(Cry) genes as well as a spectrum of clock-controlled genes
(CCGs). Subsequently, accumulation of PER/CRYprotein
complexes inhibits the BMAL1/CLOCK activity, leading
to rhythmic repression of their own transcription and
of other CCGs. Many of the known CCGs encode rate-
limiting enzymes and transcription factors that play
pivotal roles in cellular metabolism and function. None-
theless, the battery of genes under circadian regulation is
largely tissue-specific so that circadian clocks modulate
physiological processes unique to each organ (Panda et al.
2002; Gossan et al. 2013).
Daily changes in the environment (cycles in light/dark-
ness, feeding, rest–activity, and temperature fluctuations)
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inevitably expose the mammalian cells and tissues to
periodic challenges, including oxidative insults from en-
vironmental toxins/pollutants and endogenously pro-
duced reactive metabolites as products of respiration
(Patel et al. 2014). Failure to scavenge reactive oxygen
species (ROS), reactive nitrogen species (RNS), and re-
active electrophiles results in excessive oxidative stress,
leading to damage to critical macromolecules and cellu-
lar structures (Veal et al. 2007). The ability to anticipate
and withstand such cyclic insults (e.g., through effective
ROS scavenging) is therefore essential for normal pro-
tective tissue functions. There is emerging evidence that
circadian clocks regulate processes that keep ROS at
physiological levels and protect organisms from oxida-
tive stress (Stangherlin and Reddy 2013; Patel et al.
2014). Indeed, self-sustained rhythms in the cellular
redox state (Kondratov et al. 2006; O’Neil et al. 2011;
Edgar et al. 2012; Wang et al. 2012) as well as ROS-
responsive antioxidant genes (Geyfman et al. 2012; Lai
et al. 2012) have been observed in the brain and/or
peripheral tissues. Moreover, diurnal rhythms in or-
ganismal survival to ROS-generating agents have been
reported (Krishnan et al. 2008). However, the underlying
molecular mechanisms of clock-controlled regulation
of protective antioxidant responses and their role in
tissue-specific physiology and pathology are still not well
understood.
One of the major cellular antioxidant defense pathways
is mediated through the cap’n’collar basic leucine zipper
transcription factor NRF2 (nuclear factor erythroid-de-
rived 2-like 2). The current paradigm of NRF2 regulation
has mainly focused on oxidative stress-induced post-
translational mechanisms, including regulation by its
negative regulators (KEAP1, BACH1, and b-TrCP), posi-
tive regulators (DJ1, p62, and p21), or protein modifica-
tions (Itoh et al. 1999; McMahon et al. 2003; Chen et al.
2009; Komatsu et al. 2010; Chowdhry et al. 2013). In
response to oxidative stress, NRF2 protein translocates to
the nucleus and binds to the antioxidant response ele-
ments (AREs) in the promoters of many antioxidant
genes. Subsequently, NRF2 induces a transcriptional pro-
gram that maintains cellular redox balance and protects
cells from oxidative insults (Reddy et al. 2007; Malhotra
et al. 2010). NRF2 transcriptional targets include gluta-
thione cysteine ligase (GCL), involved in the rate-limiting
step of biosynthesis of antioxidant glutathione; glutathi-
one-utilizing enzymes such as glutathione S-transferase
(GST); and haeme oxigenase 1 (HMOX1), involved in the
catabolism of pro-oxidant haeme.
Nrf2-deficient mice show a decrease in both constitu-
tive and inducible expression of multiple glutathione-
dependent enzymes (McMahon et al. 2001), associated
with an impaired antioxidant defense and susceptibility
to stress-induced tissue pathologies (Cho et al. 2006; Chan
and Kan 1999). Consequently, they are highly sensitive to
many environmental toxicants and chemical inducers of
oxidant injury and fibrosis in several tissues, including
bleomycin-induced and butylated hydroxytoluene (BHT)-
induced pulmonary fibrosis (Chan andKan 1999; Cho et al.
2004; Kikuchi et al. 2010). In humans, altered NRF2
expression and impaired redox balance have been
associated with the pathogenesis of chronic lung
diseases (asthma, COPD, and idiopathic pulmonary
fibrosis) as well as lung cancer (Cho et al. 2006; Hayes
and McMahon 2009). Indeed, pharmacological target-
ing of NRF2 has emerged as a novel therapeutic ap-
proach to combat oxidative stress seen in chronic lung
diseases (Malhotra et al. 2011; Artaud-Macari et al.
2013).
Recently, mRNA levels of Nrf2 as well as several of its
target genes have been reported to show diurnal variation
in mouse livers and Drosophila heads (Beaver et al. 2012;
Xu et al. 2012). However, whether and how endogenous
circadian signals control NRF2-dependent antioxidant
activity in tissue physiology and upon pathological
challenges, especially in the lung, has not been defined.
Here we investigated the circadian rhythms in the pro-
tein levels of NRF2 and activity of the NRF2/GSH
pathway in lung tissues from light/dark cycle-entrained
mice. We also report the physiological and pathological
importance for the circadian control of the NRF2/GSH
pathway using a well-established lung fibrosis model
following a bleomycin challenge. Our data reveal a piv-
otal role for endogenous NRF2 rhythms in the lung in
coupling protective antioxidant responses to the time-
of-day susceptibility to oxidant injury and pulmonary
fibrosis.
Results
Circadian protein expression of NRF2 transcription
factor in the mouse lung
To investigate the hypothesis that the NRF2-mediated
antioxidant pathway is under circadian regulation in
the lung, we first examined the total NRF2 protein
levels in mouse lungs harvested at 4-h intervals from
mice kept in constant darkness (DD). Western blotting
using a specific NRF2 antibody (confirmed in Nrf2
knockout mouse embryonic fibroblasts [MEFs]) (data
not shown) revealed a robust rhythmic pattern of
NRF2 protein (one-way ANOVA, Tukey test, P < 0.05).
The NRF2 protein peaked at the circadian time 3–7
(CT3–CT7), reaching a trough at CT15–CT19 (Fig. 1A).
Nuclear accumulation of NRF2 protein is essential for
its subsequent activation of downstream genes (Reddy
et al. 2007; Nguyen et al. 2009). Indeed, we detected
rhythmic levels of NRF2 protein in the nuclear lung
fractions, with the maximal levels corresponding to the
peak of the total pool of NRF2 protein (P < 0.05) (Fig. 1B).
Immunostaining of NRF2 revealed a significant time-of-
day difference in the lungs that was mainly localized to
the bronchial and alveolar epithelium, with an approx-
imately threefold weaker signal at ‘‘zeitgeber’’ time 12
(ZT12; lights off) compared with ZT0 (lights on) (Fig.
1C). The rhythmic NRF2 protein expression was also
evident in the total cell lysates (Fig. 1D) and nuclei (Fig.
1E,F) of clock-synchronized Rat1 fibroblasts, demon-
strating the cell-autonomous nature of the NRF2 protein
rhythms.
Clock control of NRF2 in lung fibrosis
GENES & DEVELOPMENT 549
 Cold Spring Harbor Laboratory Press on July 14, 2016 - Published by genesdev.cshlp.orgDownloaded from 
The circadian clock exerts transcriptional control
of the Nrf2 gene via a putative E-box element
in its promoter
The circadian clock transcription factors regulate target
genes through the cis-acting elements in their gene pro-
moters (Panda et al. 2002; Rey et al. 2011). We therefore
analyzed the proximal promoter regions of the mouse,
rat, and human Nrf2 genes for clock-regulated transcrip-
tional elements, which revealed a conserved putative
E-box (CACGTG) close to their transcriptional start sites
(TSSs; 704 base pairs [bp] relative to the TSS in the
mouse Nrf2) (Fig. 2A). Next, we cloned the wild-type
mouse Nrf2Tluc promoter (1.7 kb) and generated an
E-box mutated construct. Coexpression of circadian tran-
scription activators BMAL1 and CLOCK in Rat1 cells led
to a significant stimulation ofNrf2Tluc activity (2.1-fold;
P < 0.05), similar to the activation of the Per1Tluc
promoter (containing three canonical E-box elements;
2.4-fold; P < 0.01) (Fig. 2B). Mutation of the core E-box
sequence in the Nrf2 promoter completely abolished its
induction by CLOCK/BMAL1 complexes (Fig. 2C). More-
over, coexpression of circadian transcription repressors,
either PER2 or CRY1, suppressed the CLOCK/BMAL1
transcriptional activation (Fig. 2D). Finally, stable trans-
fection of the Nrf2Tluc reporter into Rat1 cells revealed
a clearly discernible circadian rhythm with a period of
23.7 h (data not shown).
We next examined the temporal profiles of endogenous
Nrf2mRNA in the lungs of wild-type and ClockD19 mice
(a model in which the positive arm of the clock is ge-
netically disrupted) (Vitaterna et al. 1994). This revealed
a clear rhythmic expression of Nrf2 transcripts in wild-
type lungs (P < 0.05, one way ANOVA) (Fig. 2E). In
Figure 1. Circadian expression of NRF2 protein in mouse lungs and fibroblast cells. (A,B) Representative Western blots of rhythmic
NRF2 levels in total lung lysates and nuclear extracts from wild-type (WT) mice kept in DD. NRF2 densitometry (mean 6 SEM) was
normalized to b-actin or histone H1, and the highest expression set as 100%. (Gray bar) Subjective day; (black bar) subjective night.
One-way ANOVA for the effect of time, (*) P < 0.05. (C) Representative micrographs of histological lung sections showing temporal
NRF2 immunoreactivity at ZT0 versus ZT12. Brown NRF2 staining was localized mainly to bronchial epithelium (BE) and alveolar
epithelium (AE). Mean 6 SEM; (***) P < 0.001, t-test. Bar, 100 mM. (D) Representative Western blots of temporal NRF2 levels in total
lysates of Rat1 fibroblasts following serum shock. NRF2 densitometry (mean 6 SEM) was normalized to tubulin. Harvest of cells
started at 12 h after serum shock to exclude the initial gene induction. (**) P < 0.01, one-way ANOVA for the effect of time. (E, F)
Representative immunofluorescent micrographs and quantification of endogenous NRF2 in Rat1 cells at 24 h or 36 h after serum shock.
Nuclei were counterstained with DAPI. Bar, 50 mM. (***) P < 0.001, t-test.
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contrast, the mRNA rhythm of Nrf2 was abolished and
remained low across all time points in the lungs of
ClockD19 mice, consistent with a loss of rhythms in the
clock gene expression (Fig. 2E; Supplemental Fig. S1).
Consistently, knockdown of Bmal1 by siRNA signifi-
cantly reduced the levels of Nrf2 mRNA in Rat1 fibro-
blasts (P < 0.05) (Supplemental Fig. S2). In contrast, in
synchronized MEFs from arrhythmic Cry1//Cry2/
mice, a model in which the negative arm of the clock is
disrupted (Supplemental Fig. S3A,B; van der Horst et al.
1999), we observed constitutively high protein expression
levels of NRF2 as well as mRNA levels of its two target
genes (Gclm and Gsta3) (Supplemental Fig. S3C,D).
To verify the function of the putative E-box element in
the Nrf2 promoter in vivo, temporal chromatin immuno-
precipitation (ChIP) assays were performed in the wild-
type lungs using a CLOCK-specific antibody (Yoshitane
et al. 2009). As a positive control, we first observed a
time-dependent CLOCK binding to the E-box region of
theDbp promoter, a knownCLOCK target (ZT10 >ZT22;
P < 0.05) (Fig. 2F), as reported previously in the liver
(Ripperger and Schibler 2006). Rhythmic CLOCK occu-
Figure 2. Circadian clock components control Nrf2 transcription via a putative E-box element in vitro and in vivo. (A) A conserved
putative E-box element (shown in red) in the proximal promoters of the mouse, rat, and humanNrf2 gene. Sequences were aligned using
the Clustal W algorithm and shaded with the Boxshade algorithm to highlight the conserved regions (shown in black). (B, C) Effects of
CLOCK/BMAL1 overexpression on wild-type (WT) or DE-box Nrf2Tluc promoter activity in Rat1 cells. Data (mean 6 SEM) were
normalized to the b-galactosidase reporter gene and expressed relative to pCDNA3 control. The Per1Tluc reporter served as a positive
control. (*) P < 0.05; (**) P < 0.01; (ns) not significant, t-test. (D) Effects of PER2 or CRY1 overexpression in suppressing the CLOCK/
BMAL1-activated Nrf2Tluc promoter activity in Rat1 cells. (*) P < 0.05; (**) P < 0.01, t-test. (E) Temporal mRNA expression of Nrf2 in
wild-type and ClockD19 lungs. Data (mean 6 SEM) were normalized to Gapdh. (*) P < 0.05 for wild-type lungs;( ns) not significant for
ClockD19 lung; one-way ANOVA for the effect of time. (F) Temporal CLOCK binding to E-boxes in Nrf2 and Dbp gene promoters in
wild-type and ClockD19 lungs using CLOCK-specific ChIP. IgG served as a negative control. Data (mean 6 SEM) were expressed as
percent input. (*) P < 0.05; (ns) not significant, t-test. (White bar) Light phase; (black bar) dark phase.
Clock control of NRF2 in lung fibrosis
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pancy was also observed in the E-box region of the Nrf2
promoter (Fig. 2F) but not in the distal region of the
promoter (Supplemental Fig. S4A). There was a signifi-
cantly higher binding of CLOCK at ZT4 as compared
with ZT16, coinciding with the peak and trough expres-
sion of Nrf2 mRNA, respectively. Moreover, CLOCK
binding to the Nrf2 promoter was arrhythmic and re-
mained at an intermediate level in the ClockD19 lungs
(Fig. 2F). Together, these results demonstrate that the
Nrf2 gene is directly regulated by the core clock compo-
nents in vitro and in vivo through the conserved E-box
element in its promoter.
Rhythmic promoter binding of NRF2 drives
oscillations of ARE-regulated antioxidant genes
involved in glutathione homeostasis
Upon nuclear translocation, NRF2 protein binds to the
AREs in the promoters of its target genes and thus
maintains both basal and inducible expression of many
antioxidant genes (Nguyen et al. 2009; Malhotra et al.
2010). The rhythmic nuclear NRF2 levels prompted us to
examine whether the expression of ARE-regulated NRF2
target genes is also rhythmic. Temporal quantitative PCR
(qPCR) of the mouse lungs demonstrated robust endoge-
nous circadian rhythms for a number of NRF2 target
genes, including Gclm, Gsta3, and Hmox1 (P < 0.05) (Fig.
3A; Supplemental Fig. S5), as well as a core clock gene,
Bmal1 (P < 0.001) (Supplemental Fig.S5). To investigate
the hypothesis that NRF2 may be rhythmically recruited
to the AREs in the promoters of antioxidant genes in vivo,
we performed temporal ChIP assays in the mouse lungs
using an anti-NRF2 antibody. Here, we detected strongly
rhythmic NRF2 binding specifically to the promoter
regions spanning the well-characterized AREs (Malhotra
et al. 2010) in Gclm and Gsta3 gene promoters (Fig. 3B;
Supplemental Fig. S4B). We observed significantly higher
promoter occupancy at ZT0 and ZT6 (light phase) and
lower occupancy at ZT12 and ZT18 (dark phase). The
peak of NRF2 binding during light phase is in agreement
with its maximal nuclear expression and the peaks of
Gclm and Hmox1 mRNAs in the lung. Interestingly,
despite maximal NRF2 binding to the Gsta3 promoter
during the light phase, Gsta3mRNA peaked during early
subjective night, suggesting that additional phase delay
mechanisms may be at play, such as the availability of
Figure 3. Circadian rhythm of NRF2 binding to ARE drives rhythmic oscillations of genes involved in glutathione synthesis
and utilization. (A) Temporal mRNA levels of NRF2 targets in wild-type (WT) mouse lungs (DD). Data (mean 6 SEM) were normalized
toGapdh, and the lowest expression was set as 1. (*) P < 0.05, one-way ANOVA. (B) Rhythmic NRF2 occupancy on AREs of antioxidant
gene promoters in wild-type mouse lungs by NRF2-specific ChIP. The position of each ARE in relation to the TSS is shown. Mean 6
SEM. (*) P < 0.05; (**) P < 0.01, t-test. (White bars) Light phase; (black bars) dark phase. (C) Temporal mRNA profiles of NRF2 target
genes and clock gene Dbp in MEFs from wild-type and Nrf2 knockout (KO) mice following serum shock. Harvest of cells started at 28 h
after serum shock. Data (mean 6 SEM) were normalized to Gapdh. (*) P < 0.05 for all six genes in wild type; not significant for Nrf2
knockout MEFs (except Hmox1 and Dbp; [*] P < 0.05), one-way ANOVA for the effect of time. (D) Temporal levels of reduced
glutathione (GSH) in MEFs from wild-type and Nrf2 knockout mice following serum shock. Data (mean 6 SEM) were normalized to
cellular counts and quantified using standard curve for reduced GSH. (**) P < 0.01; (ns) not significant, t-test.
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cofactors, as shown for the transcription factor BMAL1
(Rey et al. 2011), or post-transcriptional processing
(Patel et al. 2014). The difference in the timing of
maximal expression may be necessary for the specific
function of individual NRF2 targets.
To investigate whether NRF2 is required for the rhyth-
mic expression of antioxidant genes, we performed tem-
poral qPCR for a panel of known NRF2 target genes
in clock-synchronized MEFs from wild-type and Nrf2
knockout mice. Here, we observed significantly reduced
basal expression of many antioxidant genes in Nrf2
knockout MEFs, as reported previously (Malhotra et al.
2010). Interestingly, the rhythmic patterns of genes
coding for enzymes involved in glutathione synthesis
(Gclm and Gclc) and glutathione utilization (Gsta3
and Gsta4) were either severely dampened or abolished
(Fig. 3C). In contrast, Hmox1, an inducible (but not basal)
NRF2 target, remained robustly rhythmic in Nrf2 knock-
out MEFs. Consistent with these results, the level of total
glutathione (GSH) showed a significant temporal varia-
tion in wild-type MEFs but remained constitutively low
in Nrf2 knockout MEFs (Fig. 3D). Importantly, the rhyth-
mic expression of Dbp in Nrf2 knockout MEFs (Fig. 3C)
and the behavioral free-running rhythms appear pre-
served in Nrf2 knockout mice (Supplemental Fig. S6).
These findings support a direct NRF2-dependent rhyth-
mic control of its downstream targets rather than due to
feedback actions of NRF2 on the molecular circadian
clock. All together, these data demonstrate that the periodic
NRF2 activity regulates the rhythmic GSH homeostasis
through temporally controlling a key set of genes involved
in glutathione synthesis and utilization.
Time-of-day-dependent lung response to bleomycin
challenge is coupled to temporal NRF2 activity
TheNRF2 antioxidant pathway is known to play a critical
role in combating fibrotic injury (Cho et al. 2004; Walters
and Kleeberger 2008). We therefore hypothesized that the
rhythmic NRF2 activity may gate the tissue-protective
responses to a fibrotic challenge in a time-of-day-depen-
dent manner. To test this, we used an established in vivo
mouse model of bleomycin-induced lung fibrosis (Walters
and Kleeberger 2008). Bleomycin was administered intra-
tracheally close to either the peak or nadir (ZT0 or ZT12,
respectively) of NRF2 protein expression (see Fig. 1A–C).
As expected, 7 d after bleomycin challenge, characteristic
histological changes, including areas of inflammatory cell
infiltration and alveolar wall thickening (data not shown),
were observed at both time points. In addition, we also
observed a significant increase in collagen accumulation
around the peri-bronchial regions, as revealed by Masson’s
Trichrome staining of lung sections and quantification
of fibrosis using the Ashcroft scoring system (Fig. 4A;
Ashcroft et al. 1988). However, the degree of lung fibrosis
was clearly dependent on the time of treatment and in-
versely correlated with NRF2 protein levels. A signifi-
cantly higher fibrotic score was observedwhen bleomycin
was delivered at ZT12 as compared with ZT0 (Fig. 4B),
associated with higher induction of fibrotic gene markers
(Timp1, Col1a2, and Mmp3) (Supplemental Fig. S7). Bleo-
mycin challenge is known to activate NRF2-dependent
antioxidant tissue responses (Cho et al. 2004). Following
an acute bleomycin challenge (4 h), the induction of
mRNAs for Gclc, Gsta3, and Hmox1 showed a clear
time-of-day dependence, with a significantly higher in-
duction at ZT0 than at ZT12 (P < 0.01 for all three genes)
(Fig. 4C), consistent with the hypothesis of a clock
‘‘gated’’ antioxidant tissue response.
To further establish the role of NRF2 rhythms in time-
of-day susceptibility to bleomycin-induced fibrosis, we
investigated whether the timed administration of sulfo-
raphane (SFN; a direct NRF2 activator) can reduce the
degree of bleomycin-induced fibrosis seen at the circadian
nadir in NRF2 levels. To this end, wild-type mice were
pretreated with either vehicle or SFN administered in-
traperitoneally at ZT6 (and thereafter at the same time
point on days 1, 3, and 5) prior to a single challenge with
bleomycin at ZT12 and assessed 7 d later. As a control,
mice treated with SFN alone (at ZT6) showed increased
NRF2 protein levels in the lungs at ZT12 as compared
with vehicle treatment (data not shown). Here, the degree
of bleomycin-induced lung fibrosis was significantly re-
duced by the timed SFN treatments (P < 0.05) (Fig. 4D).
Consistent with these findings, the bleomycin-induced
expression of fibrotic markers (Col1a2, Timp1, Mmp3,
and Ctgf) was significantly blunted by SFN treatment
(Fig. 4E). All together, these results strongly support a
role for NRF2 rhythms in coupling antioxidant response
to time-of-day susceptibility to bleomycin-induced lung
fibrosis. Moreover, these findings suggest that timed
SFN treatment might protect the lungs from oxidative
challenges, especially those that fall within the nadir of
NRF2 activity.
Altered NRF2/GSH pathway activity in the ClockD19
lungs is associated with increased markers
of oxidative damage and fibrotic injury
Our data indicate that rhythmic NRF2 activity is coupled
to the clock gated protective lung responses. To further
establish the requirement of the functional circadian
clock, we used the ClockD19 mouse model to investigate
changes in the NRF2 pathway activity. Consistent with
the loss of Nrf2 mRNA rhythmicity in the ClockD19
lungs, NRF2 protein expression was constitutively low
and arrhythmic (Fig. 5A). Moreover, ChIP assays revealed
an arrhythmic and low NRF2 occupancy in the ARE
region of the promoters for Gclm and Gsta3 (Fig. 5B).
While qPCR revealed robust time-of-day-dependent mRNA
expression of Gclm and Gsta3 in wild-type lungs, their
expression in theClockD19 lungs remained constitutively
lower, at levels similar to or below the trough expression
in wild-type lungs (Fig. 5C).
In an attempt to test the hypothesis that the ClockD19
lungs were more prone to bleomycin-induced fibrotic
injury, unexpectedly, we identified a spontaneous fibrotic-
likephenotype inClockD19 lungs evenwithout a bleomycin
challenge. We found a significantly increased deposition of
collagen fibers around the bronchioles in ClockD19 com-
Clock control of NRF2 in lung fibrosis
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pared with wild-type lungs (P < 0.001) (Fig. 6A). Consis-
tently, the expression of fibrotic marker genes (Mmp3 and
Ctgf) was significantly elevated in ClockD19 lungs (Fig.
6B). A reduced GSH level is known to be involved in the
fibrotic injury and remodeling processes (Liu and Gaston
Pravia 2009). To explore the underlying mechanisms for
the observed lung phenotype, we compared the temporal
levels of reduced glutathione, a major antioxidant output
of the NRF2 pathway. In wild-type lungs, we found a
significantly higher level of reduced GSH at ZT0 com-
pared with ZT12 (Fig. 6C). In contrast, ClockD19 lungs
showed constitutively lower levels of reduced GSH,
equivalent to the nadir level in wild-type lungs. Similar
alterations in GSH level were also found in synchronized
ClockD19MEFs, which could partially be restored by SFN
treatment (Supplemental Fig. S8; Higgins et al. 2009), sup-
porting the involvement of NRF2. To determine whether
the low GSH levels in ClockD19 lungs correlated with an
increased oxidative burden, we temporally examined the
lung protein carbonylation levels (a marker of oxidative
damage). We observed a time-dependent change in the
protein carbonyl levels in wild-type lungs, which were
anti-phasic to the reduced GSH levels (Fig. 6D). In con-
trast, protein carbonylation levels remained high at both
time points in ClockD19 lungs, consistent with a consti-
tutive decline in GSH levels. These data support the
hypothesis that the functional clock is required in co-
ordinating the temporal activation of the NRF2/GSH
pathway in the lung, disruption of which contributes to
the increased susceptibility of the lung to cyclic oxidative
stress and profibrotic challenges.
Discussion
It has recently been suggested that circadian clocks may
mediate the protective responses to oxidative stress
Figure 4. Time-of-day-dependent lung response to bleomycin challenge is coupled to temporal NRF2 activity. (A) Representative
mouse lung sections were stained with Masson’s Trichrome solution to reveal collagen fiber deposition (blue staining) and overall
fibrosis. Wild-type (WT) mice were treated with bleomycin (n = 8) or saline (n = 5) at either ZT0 or ZT12 and, 7 d later, were sacrificed
for tissue processing. Bar, 200 mM. (B) Lung sections in A were scored for fibrosis according to the Ashcroft scoring system. Mean 6
SEM; (***) P < 0.001, saline versus bleomycin, t-test; (*) P < 0.05, ZT0 versus ZT12, two-way ANOVA. (C) Fold induction in wild-type
lung mRNA levels of NRF2 targets (Gclc, Gsta3, and Hmox1) following bleomycin delivered at ZT0 or ZT12. Data (mean 6 SEM) were
expressed relative to saline controls at the respective time points. (**) P < 0.01, two-way ANOVA. (D,E) SFN treatment partially rescues the
lung fibrosis phenotype, as revealed by Masson’s Trichrome staining (with lower Ashcroft score) and reduced gene induction for fibrotic
markers (Timp1,Col1a2,Mmp3, andCtgf). Wild-typemice were treated with either saline (n = 3), bleomycin (n = 4), or SFN plus bleomycin
(n = 5) and, 7 d later, were sacrificed for histological and gene expression analysis. Mean 6 SEM; (*) P < 0.05; (**) P < 0.01, t-test.
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(Stangherlin and Reddy 2013; Patel et al. 2014). However,
the underlying clock-controlled molecular mechanisms
and their role in tissue-specific physiology are still poorly
understood. In this study, we identified the circadian
clock as an endogenous molecular regulator of the
NRF2/glutathione-mediated antioxidant defense path-
way in the mouse lung, which couples the protective
antioxidant response to the time-of-day variation in
susceptibility to oxidant injury and pulmonary fibrosis.
Based on our findings, we propose a working model de-
picting how the circadian clock exerts its regulation of
protective antioxidant responses in the lung through the
control of transcription factor NRF2 under physiological
conditions (Fig. 7). The circadian transcription factors
CLOCK and BMAL1 positively regulate Nrf2 transcrip-
tion through temporal control of the E-box element in the
Nrf2 gene promoter. NRF2 protein thus accumulates in
a circadian manner and drives circadian transcription
of a key set of antioxidant genes involved in glutathione
metabolism (such as Gclm and Gsta3). The periodic
NRF2 activity is exerted through its rhythmic recruit-
ment to the AREs in the promoters of target antioxidant
genes andmediates a time-coordinated protection against
oxidative tissue injury and fibrotic damage.
Indeed, using an in vivo bleomycin-induced pulmonary
fibrosis model, we show for the first time that, in the
lung, the acute induction of the NRF2-mediated antiox-
idant response is temporally ‘‘gated’’ by the clock and
coupled to a time-dependent resistance to fibrotic injury.
Importantly, a scheduled pharmacological activation of
NRF2 in vivo was able to significantly mitigate the
decrease in resistance to fibrotic effects of bleomycin
delivered at the circadian nadir in NRF2 levels. More-
over, in the lungs of ClockD19 circadian mutant mice, the
altered temporal regulation of NRF2 antioxidant activity
was associated with diminished glutathione levels, in-
creased oxidative protein damage, and a spontaneous
fibrotic-like phenotype. All together, our findings high-
light an important role of the circadian clock in the
regulation of the NRF2/GSH-mediated antioxidant re-
sponse and its coupling to oxidative/fibrotic injury in
the lung.
Our study builds on the recent reports implicating the
role of the circadian clock in the regulation of tissue
physiology through redox-dependent mechanisms
(Kondratov et al. 2006; Lai et al. 2012; Wang et al.
2012; Musiek et al. 2013; Peek et al. 2013). For instance,
direct circadian regulation of antioxidant genes (Nqo1
and Aldh2) has been reported in the cerebral cortex, and
the circadian regulation of NAD+-dependent histone
deacetylase SIRT3 has been implicated in mitochondrial
oxidative metabolism. Our findings reveal a novel aspect
of circadian clock function in modulating pulmonary
fibrotic responses, which is mediated through its control
of the NRF2 transcription factor.
Current research concerning NRF2 regulation has
largely focused on the post-translational mechanisms,
especially via a KEAP1-based protein turnover in re-
sponse to various electrophilic/oxidative stresses. In this
model, NRF2 proteins are tethered to the cytoplasm by
Figure 5. Loss of rhythmic NRF2 pathway activity in ClockD19 lungs. (A) Representative Western blots of diurnal NRF2 levels in total
lung lysates from wild-type (WT) and ClockD19 mice. NRF2 densitometry (mean 6 SEM) was normalized to tubulin and expressed
relative to wild-type ZT0. (*) P < 0.05 for wild type; not significant for ClockD19, one-way ANOVA for the effect of time. (White bar)
Light phase; (black bar) dark phase. (B) Temporal (ZT0 vs. ZT12) ChIP assays for the ARE regions of NRF2 targets (Gclm and Gsta3) in
wild-type and ClockD19 lungs using NRF2-specific antibody. Data (mean 6 SEM) were expressed as percent input. (*) P < 0.05; (ns) not
significant, t-test. (C) Temporal mRNA levels of Gclm and Gsta3 in wild-type and ClockD19 lungs at ZT0 versus ZT12. Data (mean 6
SEM) were normalized to Gapdh. (*) P < 0.05; (ns) not significant, t-test.
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KEAP1 and targeted for proteasomal degradation (Hayes
and McMahon 2009). It was therefore thought that only a
small pool of NRF2 protein can escape from its degrada-
tion in the cytosol and translocate to the nucleus under
basal conditions. In response to oxidative stress, however,
oxidative inactivation of KEAP1 and de novo synthesis of
NRF2 drive sustained nuclear NRF2 accumulation (Itoh
et al. 2010). Our data reveal a rhythmic nuclear abun-
dance of endogenous NRF2 protein in tissues and cells
that accompanies the rhythmic levels in the total pool of
NRF2 protein. These results are supported by previous
studies in the mouse liver and pancreatic b cells that
identified Nrf2 as one of the clock-controlled targets (Xu
et al. 2012; Lee et al. 2013). It is therefore conceivable that
during the circadian peak of NRF2 protein, increased
levels ofNRF2may saturate the binding capacity of KEAP1,
thus allowing NRF2 to escape from the KEAP1-mediated
degradation and translocate to the nucleus, where it in-
duces higher expression of antioxidant genes. In contrast,
during the nadir phase of NRF2 expression, KEAP1 may
exert tighter control of NRF2 activity through increased
NRF2 degradation. In this way, the regulation of NRF2
nuclear activity appears to be restricted to a particular cir-
cadian window, gated by both the clock-controlled mRNA
synthesis and the KEAP1-based protein degradation.
Previous ChIP-seq (ChIP combined with deep sequenc-
ing) and microarray studies have revealed that, in addi-
tion to stress-induced antioxidant gene expression, NRF2
directly controls basal expression of numerous antioxi-
dant genes via AREs in their promoters (Reddy et al. 2007;
Malhotra et al. 2010). Here we show that, under physio-
logical conditions in the lung, the protein levels and
recruitment of NRF2 to gene-specific antioxidant gene
promoters is under rhythmic clock regulation. Nrf2-de-
ficient MEFs are not capable of maintaining circadian
rhythms of a number of key antioxidant genes involved in
glutathione homeostasis and show arrhythmic and re-
duced levels of its major antioxidant output glutathi-
Figure 6. A fibrotic-like injury in the lungs of ClockD19 mice is associated with increased oxidative damage. (A) Representative wild-
type (WT) and ClockD19 mouse lung sections processed for Masson’s Trichrome staining. Bar, 200 mM. Quantification of lung fibrosis in
wild-type (n = 4) and ClockD19 (n = 5) mice was performed by the Ashcroft scoring system. (***) P < 0.001, t-test. (B) mRNA levels of
fibrotic markers (Ctgf and Mmp3) in wild-type versus ClockD19 lungs. Data (mean 6 SEM) were normalized to Gapdh. (**) P < 0.01,
t-test. (C) Temporal levels of reduced glutathione (GSH) in wild-type and ClockD19 lungs at ZT0 versus ZT12. Data (mean 6 SEM)
were normalized to total protein concentration and quantified using a standard curve for reduced GSH. (**) P < 0.01; (ns) not
significant, t-test. (D) Protein carbonyl levels in wild-type and ClockD19 lungs at ZT0 versus ZT12 using oxy blotting with anti-
dinitrophenyl (DNP) antibody. (+DNPH ) Proteins derivatized with 2,4-dinitrophenylhydrazine (DNPH); (DNPH) proteins prepared
in the absence of DNPH. Data (mean 6 SEM) were normalized to tubulin and expressed relative to wild-type at ZT12. (**) P < 0.01;
(ns) not significant, t-test.
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one. Moreover, in ClockD19 circadian mutant mice, the
altered regulation of NRF2 activity was also associated
with reduced expression of genes involved in glutathi-
one metabolism as well as total glutathione levels.
Since both the behavioral free-running rhythms in Nrf2
knockout mice and Dbp mRNA rhythm in Nrf2 knock-
out MEFs appear preserved, this highlights the essen-
tial role of NRF2 in mediating rhythmic glutathione
homeostasis.
Changes in the lung NRF2 expression and GSH metab-
olism as well as elevated protein carbonyl content are
recognized as central features of many human chronic
lung diseases, including idiopathic pulmonary fibrosis,
cystic fibrosis, acute respiratory distress syndrome, and
COPD (Rahman and MacNee 2000; Dalle-Donne et al.
2003; Rangasamy et al. 2004; Reddy et al. 2007; Liu and
Gaston Pravia 2009). Nrf2 knockout mice show an in-
creased propensity toward stress-induced tissue patholo-
gies, including bleomycin-induced pulmonary fibrosis
(Chan and Kan 1999; Cho et al. 2004). We observed
temporal variations in protein carbonylation in wild-type
mouse lungs, which were inversely correlated with
changes in the reduced GSH levels. We show a time-of-
day-dependent variation in the susceptibility to bleomycin-
induced lung fibrosis in vivo, which was inversely corre-
lated with the daily rhythm in the NRF2/GSH-dependent
antioxidant response. Moreover, this time-dependent di-
urnal variation in sensitivity could be mitigated by the
scheduled administration of the NRF2 activator SFN,
highlighting the NRF2 pathway as a potential chronother-
apeutic target to prevent or slow down the progression of
oxidant-induced injury and fibrosis. In the lungs of
ClockD19 circadian mutant mice, the altered temporal
NRF2 activity was associated with constitutively lower
levels of GSH, elevated protein oxidative damage, and a
spontaneous fibrotic-like phenotype. We therefore specu-
late that decreased glutathione levels and GSH-dependent
detoxification contribute to the increased oxidative/
fibrotic damage in ClockD19 circadian mutant mice. Con-
sistent with our findings, Bmal1 knockout mice showed
accelerated aging associated with constitutively high tis-
sue ROS levels and oxidative stress-induced senescence
(Kondratov et al. 2006, 2009), which could be rescued using
glutathione precursor NAC (Khapre et al. 2011).
In conclusion, we identified the molecular circadian
clock as an endogenous regulatory mechanism control-
ling the rhythmic activity of the redox-sensitive tran-
scription factor NRF2 in the mouse lung. We also reveal
the physiological significance of this rhythmic control in
modulating tissue susceptibility to oxidative injury and
pulmonary fibrosis. Given the role of NRF2 in human
fibrotic diseases, we envisage a scenario in which circa-
dian misalignments (e.g., caused by genetic variation or
aging) may compromise the rhythmic activation of the
NRF2-mediated antioxidant defense, leading to increased
oxidative damage.Moreover, once fibrosis develops, there
is no way to revert the phenotype. Current therapy that
aims to slow down the progression of fibrotic diseases is
often ineffective (Liu and Gaston Pravia 2009); our study
implicates the need for considering circadian timing
mechanisms, including timed drug administration (chro-
nopharmacology) (Levi and Schibler 2007). Therefore,
a major challenge in the future will be to understand
how these circadian mechanisms affect tissue function in
human disease.
Materials and methods
Animals and tissue collection
All experiments were conducted under the aegis of the 1986
Home Office Animal Procedures Act (UK). Mice were main-
tained on a standard maintenance chow under a 12-h light/12-h
dark (12:12 LD) regimen. PER2TLuc and ClockD19 mice on a
C57BL/6J background were generated by Professor Joseph
Takahashi. ClockD19 mice were subsequently bred with PER2Luc
mice. For circadian tissue collections or experiments with
bleomycin-induced fibrosis, 8-wk-old female C57BL/6J mice
(Harlan Laboratories) were placed under 12:12 LD cycles for
2 wk before their release into DD. Animals were sacrificed by
cervical dislocation in complete darkness using an infrared
viewer, and lung tissues were harvested at 4-h intervals, begin-
ning at 39 h after the start of DD. All tissues (circadian and
diurnal collections) were either freshly used or snap-frozen in
liquid nitrogen and kept at 80°C until use.
Reagents and plasmids
Bleomycin was purchased from ENZO. SFN was purchased from
LKT Laboratories. All other chemicals were purchased from
Sigma unless specified otherwise. mCLOCK and hBMAL1 ex-
pression plasmids and pGL3-mPer1Tluc were kind gifts fromDr.
Kazuhiro Yagita. The lentiviral mPer2Tluc construct was pre-
viously described (Lu et al. 2010). The generation of wild-type
and DE-box mNrf2Tluc constructs is described in the Supple-
mental Material.
Real-time bioluminescence recordings
Bioluminescence from the organotypic lung slices of wild-type
and ClockD19 mice (on a PER2TLuc background) (Yoo et al.
2004) or from MEFs with lentivirally transduced Per2Tluc
Figure 7. A hypothetical model depicting how the circadian
clock exerts regulation of the NRF2 pathway under physiolog-
ical conditions.
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reporters was recorded by photomultiplier tubes (PMTs;
Hamamatsu) housed in a light-tight incubator at 37°C and 0%
CO2 as described previously (Meng et al. 2008). The lung tissue
slices were cultured in the recording medium (phenol red-free
DMEM supplemented with 10% fetal bovine serum, 3.5 mg/mL
glucose, 25 U/mL penicillin, 25 mg/mL streptomycin, 0.1 mM
luciferin, 10 mMHEPES-NaOH at pH 7) on Millicell cell culture
inserts (Millipore). Cellular clocks were synchronized by a well-
established serum shock protocol using 50% horse serum (for
2 h). Data were presented as photon counts per minute.
ChIP assays
Freshly harvested lung tissues were homogenized and cross-
linked in 1% (v/v) formaldehyde. Lung nuclear lysates were
sonicated (;500 bp) using Bioruptor (Diagenode), and 5% of each
sheared chromatin sample was saved as an input control.
Following preclearing, lung chromatin was incubated overnight
at 4°C with the following antibodies: 1 mg/mL rabbit anti-NRF2
(Santa Cruz Biotechnology), 4mg/mLmouse anti-CLOCK (CLSP3)
(Yoshitane et al. 2009; in-house), and 1 mg/mL control rabbit or
mouse IgGs (Millipore). Immunoprecipitated DNA fragments
were captured using protein G magnetic Dynabeads (Life Tech-
nologies). After a series of washes, proteinase K digestion, and
reverse cross-linking, DNA was eluted and cleaned up (Qiagen).
Real-time qPCR was performed using TaqMan-based primer
pairs/probes (Supplemental Table 1) to amplify the promoter
regions spanning the conserved E-box or AREs. The amount of
precipitated DNA in each sample was quantified according to
the percent inputmethod, inwhichCt values of each samplewere
normalized to the adjusted Ct values of their respective inputs
(corrected for dilution factor) and expressed as percent input.
Tissue glutathione (GSH) assay
Frozen lung tissues (100 mg) were homogenized in ice-cold 5%
sulfosalicylic acid (Sigma) to minimize oxidation of reduced
GSH. The diluted acid supernatants were used for GSH mea-
surements, and the acid-precipitated protein was used for protein
determination using a BCA protein assay kit (Pierce). Free
reduced glutathione was determined using the luminescence-
based GSH-Glow glutathione assay (Promega), which is based on
the conversion of a luminogenic probe in the presence of reduced
GSH in a reaction catalyzed by GST. Luminescence measure-
ments were performed in triplicates for each biological replicate
and processed in a single run to aid comparative quantification.
Relative luminescence units (RLUs) were corrected for back-
ground luminescence and converted to nanomoles per milligram
of protein using a standard curve for reduced GSH.
Protein carbonylation assay
To measure protein carbonylation, lung protein lysates were
processed using the Oxyblot protein oxidation detection kit
(Millipore). Briefly, the carbonyl groups in the SDS-denatured
proteins were derivatized to 2,3-dinitrophenyl hydrazone (DNP-
hydrazone) by reaction with 2,4-dinitrophenylhydrazine (DNPH)
followed by SDS-PAGE. Immunoblot detection of protein car-
bonyls was performed using rabbit anti-DNP primary antibody
and goat anti-rabbit HRP-conjugated secondary antibody. As
a negative control, proteins were derivatized using a derivatiza-
tion control solution. Protein carbonylation levels were ana-
lyzed using National Institutes of Health ImageJ software by
determining the values obtained for total protein density within
each protein lane and were normalized to tubulin density for each
sample.
Bleomycin-induced lung fibrosis model
All animal procedures were carried out in accordance with the
Animals Scientific Procedures Act (1986). Female wild-type
(C57/BL6), PER2TLuc, or clockD19 mice (aged 8–12 wk) were
dosed intratracheally with 1 mg/kg clinical-grade bleomycin
(30 mL volume; ENZO) or vehicle (saline) at either ZT0 (lights on)
or ZT12 (lights off). Tissues were collected either 4 h later for
RNA analysis of acute gene transcription or 7 d later (at ZT6) for
histological assessment and long-term gene expression. The
lungs were lavaged post-mortem via an incision in the trachea,
with 1 mL of 10 mM EDTA and 1% BSA. For acute gene
expression assays, fresh lung lobes were dissected and snap-
frozen. For histological samples, 1 mL of 4% PFA was delivered
via the trachea to inflate the lungs. The trachea was clamped off,
and the lungs were removed en bloc and fixed in 4% PFA
overnight at 4°C. After fixing, the middle right lobe was removed
for RNA extraction, while the left lobe was processed for
histological assessment. Lung slices at 5 mm were stained with
Masson’s Trichrome solution following the standard procedure
within our core histology facilities (University of Manchester).
The histological slides were imaged and scored numerically
using the Ashcroft scoring system by two experienced re-
searchers blinded to the treatment groups. For rescue studies,
10 mg/kg SFN (LKT Laboratories) or 10 mg/kg vehicle (saline)
was administered intraperitoneally at ZT6 prior to a bleomycin
challenge at ZT12 and then every other day for 7 d before tissue
processing.
Immunocytochemistry and immunohistochemistry
Immunostaining was performed as previously described (Pekovic
et al. 2011). Briefly, cells were fixed with 4% formaldehyde at
12-h intervals after stimulation with 50% horse serum. For
immunocytochemistry, rabbit anti-NRF2 antibody (sc-722,
Santa Cruz Biotechnology) was applied at 1:200 overnight at
4°C. The secondary antibody was donkey anti-rabbit IgG conju-
gated to Alexa Fluor 555 (Molecular Probes). Nuclei were
visualized by DAPI using VectaShield Hard-Set (Vector Labora-
tories). Cells on cover slips were imaged using a Zeiss Axiovert
40 CFL inverted microscope (Carl Zeiss). Intensity of NRF2
immunostaining was quantified using ImageJ software by mea-
suring the integrated density of fluorescence in 50–100 cells after
correcting for background fluorescence, and the results were
confirmed in three independent experiments.
For immunohistochemistry, lung tissues were fixed with 4%
formaldehyde, paraffin-embedded, and sectioned at 5 mm. Slides
were dewaxed, rehydrated, and processed for antigen retrieval.
Endogenous peroxidases were blocked in 3% H2O2 for 30 min.
Blocking was carried out for 1 h in 2% normal goat serum, after
which sections were incubated in anti-NRF2 antibody at 1:50
dilution overnight at 4°C in a humidified chamber. Slides were
incubated in biotinylated secondary donkey anti-rabbit antibody
(Vector Laboratories) diluted 1:800 in 1% BSA. ABC solution and
the DAB (3939-diaminobenzidine) substrate kit (Vector Laborato-
ries) were used to visualize positive NRF2 staining. To confirm
the antibody specificity, immunohistochemistry was performed
on control sections without the addition of either primary or
secondary antibodies.
Statistical analyses
Data were evaluated using Student’s t-test, one-way ANOVA
with Tukey test, or two-way ANOVA for multiple comparisons
as indicated. Results are presented as mean 6 SEM from at least
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three independent experiments. Differences were considered
significant at the values of P < 0.05 (*), P < 0.01 (**), and P <
0.001 (***).
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